Photocure ASA: Results for the second quarter of 2021

STOCKHOLM, Aug. 11, 2021 /PRNewswire/ — Photocure ASA (OSE:PHO) today reported Hexvix®/Cysview® revenues of NOK 88.9 million in the second quarter of 2021 (Q2 2020: NOK 53.5), and EBITDA of NOK 5.8 million (NOK -8.9 million), driven by growth in the U.S….

Click here to view the original article.